These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

448 related items for PubMed ID: 16193786

  • 21. Moving toward focal therapy in prostate cancer: dual-isotope permanent seed implants as a possible solution.
    Todor DA, Barani IJ, Lin PS, Anscher MS.
    Int J Radiat Oncol Biol Phys; 2011 Sep 01; 81(1):297-304. PubMed ID: 21536392
    [Abstract] [Full Text] [Related]

  • 22. The impact of edema on planning 125I and 103Pd prostate implants.
    Yue N, Dicker AP, Nath R, Waterman FM.
    Med Phys; 1999 May 01; 26(5):763-7. PubMed ID: 10360539
    [Abstract] [Full Text] [Related]

  • 23. Prostate brachytherapy postimplant dosimetry: seed orientation and the impact of dosimetric anisotropy in stranded implants.
    Chng N, Spadinger I, Rasoda R, Morris WJ, Salcudean S.
    Med Phys; 2012 Feb 01; 39(2):721-31. PubMed ID: 22320782
    [Abstract] [Full Text] [Related]

  • 24. Treatment planning consideration for prostate implants with the new linear RadioCoil 103Pd brachytherapy source.
    Meigooni AS, Awan SB, Rachabatthula V, Koona RA.
    J Appl Clin Med Phys; 2005 Feb 01; 6(3):23-36. PubMed ID: 16143789
    [Abstract] [Full Text] [Related]

  • 25. A dynamic model for the estimation of optimum timing of computed tomography scan for dose evaluation of 125I or 103Pd seed implant of prostate.
    Yue N, Dicker AP, Corn BW, Nath R, Waterman FM.
    Int J Radiat Oncol Biol Phys; 1999 Jan 15; 43(2):447-54. PubMed ID: 10030274
    [Abstract] [Full Text] [Related]

  • 26. A Monte Carlo study on the effect of seed design on the interseed attenuation in permanent prostate implants.
    Afsharpour H, D'Amours M, Coté B, Carrier JF, Verhaegen F, Beaulieu L.
    Med Phys; 2008 Aug 15; 35(8):3671-81. PubMed ID: 18777927
    [Abstract] [Full Text] [Related]

  • 27. Influence of breast composition and interseed attenuation in dose calculations for post-implant assessment of permanent breast 103Pd seed implant.
    Afsharpour H, Pignol JP, Keller B, Carrier JF, Reniers B, Verhaegen F, Beaulieu L.
    Phys Med Biol; 2010 Aug 21; 55(16):4547-61. PubMed ID: 20668347
    [Abstract] [Full Text] [Related]

  • 28. Monte Carlo dosimetry for 125I and 103Pd eye plaque brachytherapy.
    Thomson RM, Taylor RE, Rogers DW.
    Med Phys; 2008 Dec 21; 35(12):5530-43. PubMed ID: 19175111
    [Abstract] [Full Text] [Related]

  • 29. Effect of edema, relative biological effectiveness, and dose heterogeneity on prostate brachytherapy.
    Wang JZ, Mayr NA, Nag S, Montebello J, Gupta N, Samsami N, Kanellitsas C.
    Med Phys; 2006 Apr 21; 33(4):1025-32. PubMed ID: 16696479
    [Abstract] [Full Text] [Related]

  • 30. The effect of the radial function on I-125 seeds used for permanent prostate implantation.
    Pickett B, Pouliot J.
    Med Dosim; 2004 Apr 21; 29(3):204-9. PubMed ID: 15324917
    [Abstract] [Full Text] [Related]

  • 31. Recommendations of the American Association of Physicists in Medicine regarding the impact of implementing the 2004 task group 43 report on dose specification for 103Pd and 125I interstitial brachytherapy.
    Williamson JF, Butler W, Dewerd LA, Huq MS, Ibbott GS, Mitch MG, Nath R, Rivard MJ, Todor D, American Association of Physicists in Medicine.
    Med Phys; 2005 May 21; 32(5):1424-39. PubMed ID: 15984693
    [Abstract] [Full Text] [Related]

  • 32. Monte Carlo calculated TG-43 dosimetry parameters for the SeedLink 125Iodine brachytherapy system.
    Medich DC, Munro JJ.
    Med Phys; 2003 Sep 21; 30(9):2503-8. PubMed ID: 14528972
    [Abstract] [Full Text] [Related]

  • 33. Monte Carlo calculations and experimental measurements of dosimetry parameters of a new 103Pd source.
    Li Z, Palta JR, Fan JJ.
    Med Phys; 2000 May 21; 27(5):1108-12. PubMed ID: 10841416
    [Abstract] [Full Text] [Related]

  • 34. Influence of source batch S dispersion on dosimetry for prostate cancer treatment with permanent implants.
    Nuñez-Cumplido E, Perez-Calatayud J, Casares-Magaz O, Hernandez-Armas J.
    Med Phys; 2015 Aug 21; 42(8):4933-40. PubMed ID: 26233219
    [Abstract] [Full Text] [Related]

  • 35. Potential impact of prostate edema on the dosimetry of permanent seed implants using the new 131Cs (model CS-1) seeds.
    Chen Z, Deng J, Roberts K, Nath R.
    Med Phys; 2006 Apr 21; 33(4):968-75. PubMed ID: 16696473
    [Abstract] [Full Text] [Related]

  • 36. Dose perturbation effects in prostate seed implant brachytherapy with I-125.
    Mobit P, Badragan I.
    Phys Med Biol; 2004 Jul 21; 49(14):3171-8. PubMed ID: 15357190
    [Abstract] [Full Text] [Related]

  • 37. Investigation of interseed attenuation and tissue composition effects in (125)I seed implant prostate brachytherapy.
    Mason J, Al-Qaisieh B, Bownes P, Henry A, Thwaites D.
    Brachytherapy; 2014 Jul 21; 13(6):603-10. PubMed ID: 24913435
    [Abstract] [Full Text] [Related]

  • 38. Comparative study of permanent interstitial prostate brachytherapy post-implant evaluation among seven Italian institutes.
    Mangili P, Stea L, Cattani F, Lappi S, Giglioli F, Calamia E, Ziglio F, Martinelli R, Longobardi B.
    Radiother Oncol; 2004 Apr 21; 71(1):13-21. PubMed ID: 15066291
    [Abstract] [Full Text] [Related]

  • 39. Calculated microdosimetric characteristics of 125I and 103Pd brachytherapy seeds at different depths in water.
    Wuu CS, Chen J.
    Radiat Prot Dosimetry; 2006 Apr 21; 122(1-4):506-8. PubMed ID: 17189276
    [Abstract] [Full Text] [Related]

  • 40. Relationship between isotope half-life and prostatic edema for optimal prostate dose coverage in permanent seed implants.
    Villeneuve M, Leclerc G, Lessard E, Pouliot J, Beaulieu L.
    Med Phys; 2008 May 21; 35(5):1970-7. PubMed ID: 18561673
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.